SOHAIL ARIF: Open Payments
NPI 1386638898 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 26 payments from 8 companies in 2025. Trend: 2023 $589 · 2024 $495 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $137 |
| Lundbeck LLC | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| ABBVIE INC. | 2 | $48 |
| Indivior Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: REXULTI, ARISTADA, COBENFY, VRAYLAR, SUBLOCADE, INGREZZA, CAPLYTA.
Industry payments across FL — which companies pay providers there.
